PURA Website  |  Everx  |  Extraction  |  Research                          Get FinancialNewsMedia.com Alerts 

Privacy Policy

Puration Inc. (OTC: PURA) Breaking News - October 10, 2018

 

 

Puration, Inc. Announces New Goldman Small Cap Research Report With Speculative-Buy Rating and Target $0.25 PPS
 

DALLAS, Oct. 10, 2018- Puration, Inc. (USOTC: PURA) (“PURA”) today announced that Goldman Small Cap Research issued an updated research report on the Company. The report includes a 'speculative-buy' rating with a target price-per-share of $0.25. The report provides an in-depth overview and analysis of Puration's successes, approach, new initiatives, and upcoming milestones. To view the report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com or https://www.purationinc.com/goldman-research/.

Puration Goldman Small Cap Research Report Highlights

Puration, Inc. is a leading Texas-based, CBD-infused beverage provider. The Company’s flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market. Puration plans to introduce new beverages as well as grow its product portfolio organically as well as through targeted acquisitions. As of October 2018, the Company was set to spin off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.


According to Hemp Business Journal, the overall hemp-based CBD market is forecast to grow from $820 million in 2017 to $1.9 billion in 2022 and given that the market remains fragmented, fast-growing PURA is well positioned to capture market share very quickly.

In the Opportunity Research update, analyst Rob Goldman discusses the Company’s compelling positioning, exciting opportunities, and innovative subsidiary spin-off plans.

Goldman noted, “PURA is one of the leading players in the fast-growing CBD-infused beverage arena. In fact, Puration’s flagship product has enjoyed 600% sales growth since its introducti
on in 2017. Leveraging this growth, Puration plans to execute M&A and introduce new beverage products. With double the number of CBDs found in most beverages, PURA’s EVERx CBD Infused Sports Waters reduce pain and muscle soreness.”

“Major beverage companies such as Constellation Brands, Coca-Cola have already begun joint venture with companies in the cannabis space or are devising their strategies. These recent events bode well for companies like Puration which has demonstrated sales and a strong customer base sports nutrition and fitness. To focus on its core, high-growth beverage business, PURA announced a spin-off of its cannabis cultivation segment, effective 10/11/18. This event could turn into a future bonus for shareholders.”


“In our view, these shares are trading at very low levels and offer substantial upside. A snapshot of the current valuations of 2 publicly traded cannabis beverage peers illustrates that PURA trades at a lower market cap, despite much higher sales. Thus, we believe the stock could reach higher levels as PURA executes its sales and M&A strategy.”

About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.

Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

This press release contains excerpts of our most recently published sponsored company research report on Puration, Inc. which carries a rating and a price target. The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research relied solely upon information derived from Puration, Inc. (“the Company”) authorized press releases or legal disclosures made in its filings with the U.S. Securities and Exchange Commission
http://www.sec.gov.

Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.

A Goldman Small Cap Research report, update, newsletter, article, trading alert, corporate profile, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other regulatory agency. To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visit www.goldmanresearch.com. Goldman Small Cap Research was compensated $3500 by the Company for research and distribution services, including the production of this press release.

About Puration, Inc. (OTC - PURA) Puration, Inc. is a leading Texas-based, CBD-infused beverage provider. The Company’s flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market. Puration plans to introduce new beverages as well as grow it product portfolio organically as well as through targeted acquisitions. As of October 2018, the Company was set to spin off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.

For more information, please visit: www.PurationInc.com

Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com

 

 

Puration Inc Sets Sights On 2018 Revenue Benchmark To Carve Out Leadership Stake In $1 Billion Cannabis Beverage Market Segment
 

DALLAS, Oct. 09, 2018 (- Puration, Inc. (USOTC: PURA) (“PURA”) today announced setting its sights on breaking through the $1 million revenue benchmark in 2018.  PURA is a rapidly growing cannabis beverage producer and management believes sales could exceed $1 million this year, 2018.  The company introduced EVERx CBD Sports Water last year, and it has become the leading cannabis beverage brand name in the sports nutrition marketplace.  Distribution is growing rapidly.  The company has just launched its first production run with its new labels to fill outstanding orders within new regions in the United States (and internationally).  The company’s first THC infused beverage, THCSavor, is in the works and is expected to launch soon.  The company also recently announced a pending acquisition to add yet a third cannabis beverage. According to a report by Brightfield Group, the hemp and CBD category alone is expected to be a $1 billion market by 2020 in the U.S.

 

EVERx CBD Sports Water has become the leading cannabis beverage brand name in the sports nutrition marketplace.

 

PURA announced last week the spinoff of its cannabis cultivation business.  The spinoff is part of the overall strategy for Puration to concentrate ongoing business development efforts on the company’s flourishing cannabis infused beverage business.  The spinoff announced last week has been effected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (USOTC: NOUV) (“NOUV”).  PURA has sold its cannabis cultivation business irn exchange for a convertible purchase note issued by NOUV.  All of the NOUV common shares issued in conversion of the purchase note are slated for distribution to PURA shareholders in a dividend distribution following a recapitalization of NOUV.

More details on the company’s rapidly expanding cannabis beverage business to include further details on the spinoff transaction will be included in an online presentation this Thursday, October 11th, 2018.

Learn more about Puration at 
www.purationinc.com 

Disclaimer/Safe Harbor: 
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350 

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/8f1ebf50-0016-4374-ae54-22781fff71e7

 

Source: Puration Inc.

 

---------------------------------------

About PURA:

Puration is engaged in the development of standardized and repeatable cannabis extraction processes that can deliver a consistent and high-quality concentrate for infusion into consumer food and beverage products that appeal to the recreational and wellness market segments.

The Company recently released details regarding the upcoming launch of an extraction facility in the State of Colorado where the extraction process can be utilized for both the ongoing development of cannabis treatments at the same time benefiting from the extraction and selling oil from marijuana into the legal recreational market in Colorado.

Puration, Inc. (PURA) entered the emerging cannabis sector last July when it executed an agreement to acquire select operating assets from North American Cannabis Holdings, Inc. (USMJ). Since that time, Puration has focused on developing from the acquired operating assets a standardized and repeatable extraction process to produce a variety of high-quality and consistent cannabis extracts. Previously, Puration had been developing and marketing water purification technology. In fact, Puration’s portable personal water filtered bottles remain currently available on select retails shelves.

Today, the water purification business at Puration is secondary and the development of a leading cannabinoid extraction capacity is the Company’s primary focus. The purpose of developing a leading cannabinoid extraction capacity is to provide the Company with the best available source of extracts for infusion into health and wellness consumer products. While the ‘Puration’ name was originally coined to represent the Company’s water purification business, the name still seems to be a good fit with the current cannabinoid extraction focus. Accordingly, no corporate name change is planned.

Puration extracts have been infused into a sports and fitness nutritional supplement line under the brand Name EVERx available now on a limited test market basis.

Puration’s progress since its July entry into the cannabis sector has to date not been widely publicized. Work last year quietly focused on developing extraction processes and on opening an extraction lab and infusion facility in Colorado as well as securing a large scale, commercial hemp farming operation in China. Management is just now beginning to make the Company’s past and coming progress more public.

$3 Million Cannabis Extraction 1st Year Revenue Plan

Executive Summary

Puration, Inc. has been working independently and with various partners to develop standardized and repeatable cannabis extraction processes to deliver consistent, high-quality concentrates for infusion into food and beverage consumer products for the recreational and wellness market segments.

While Puration anticipates marijuana legalization to progress, management anticipates ‘smoking’ limitations and restrictions to endure in light of the known health risks associated with smoking tobacco.

Cannabis infused food and beverage products exist in the market today, but the quality and intensity of infused concentrates can be unpredictable.

The packaging and marketing of ‘edibles’ is largely undeveloped market wide with many products packaged into plain envelopes, paper sacks and cardboard mailing tubes with low graphic quality sticker labels. Basic retail merchandizing practices are virtually non-existent. Advertising is limited primarily to homegrown social media campaigns.

Puration intends to build collaboration agreements to infuse Puration branded, high quality, consistent concentrates into select food and beverage consumer products.

Strategic Overview

Puration’s success begins with a clear operational focus and equally clear sales and marketing focus.

Extraction Operation

Through research and industry experience, various cannabis extracts have demonstrated a variety of effective pharmaceutical, wellness and recreational applications. Puration has identified specific extracts applicable to targeted wellness and recreational applications and initiated development and production. Puration will continue to bolster its capacity for delivering consistent high quality extracts by:

1. Building and operating and continuously expanding in-house extraction facilities and

2. Continuously improving its extraction process through independent research and experience, and through research and experience with select extraction partners.

Sales & Marketing

Puration will build a brand for quality and consistency of its extracts by

1. Having a great product

2. Represented by a professionally developed recognizable image

3. Co-marketed with existing brand name food and beverage consumer products.

$3 Million Forecast

The Company has entered into negotiations with a number of food and beverage consumer product companies regarding collaborations to infuse a co-branded Puration extract. The target sales objective of each collaboration agreement is $1 million dollars within the first year. Puration anticipates three collaboration agreements to be finalized promptly. The Company has more than three collaboration agreements currently under development. If Puration enters into more than three collaboration agreements, management may refine its preliminary revenue forecast upward..

SOURCE: http://www.purationinc.com/




Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG was compensated two thousand dollars for Puration Inc. news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Puration Inc. 

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.